Nogo-A and Nogo receptor expression in demyelinating lesions of multiple sclerosis

Journal of Neuropathology and Experimental Neurology

Volumn 64, Issue 2, 2005, Pages 129-138

  Satoh, Jun Ichi ^a   Onoue, Hiroyuki ^a   Arima, Kunimasa ^b   Yamamura, Takashi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Axonal regeneration; Multiple sclerosis; Nogo receptor; Nogo A; Oligodendrocytes; Reactive astrocytes

Indexed keywords

NOGO RECEPTOR; PROTEIN NOGO A; RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; AXONAL INJURY; BRAIN INFARCTION; CASE REPORT; CELL SUBPOPULATION; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVE REGENERATION; NERVOUS SYSTEM INJURY; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR BINDING; WESTERN BLOTTING;

EID: 14844310381     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/64.2.129     Document Type: Article

References (56)

1. Schwab ME, Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 1996;76:319-70
2. Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000;403:434-39
3. GrandPré T, Nakamura F, Vartanian T, et al. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000;403:439-44
4. Huber AB, Weinmann O, BrösamLe C, et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 2002;22:3553-67
5. Wang X, Chun S-J, Treloar H, et al. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 2002;22:5505-15
6. Josephson A, Widenfalk J, Widmer HW, et al. NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp Neurol 2001;169:319-28
7. Liu H, Ng CEL, Tang BL. Nogo-A expression in mouse central nervous system neurons. Neurosci Lett 2002;328:257-60
8. Hunt D, Coffin RS, Prinjha RK, et al. Nogo-A expression in the intact and injured nervous system. Mol Cell Neurosci 2003;24:1083-102
9. Liu Y-Y, Jin W-L, Liu H-L, et al. Electron microscopic localization of Nogo-A at the postsynaptic active zone of the rat. Neurosci Lett 2003;346:153-56
10. Oertle T, Huber C, van der Putten H, et al. Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J Mol Biol 2003;325:299-323
11. Oertle T, van der Haar ME, Bandtlow CE, et al. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 2003; 23:5393-406
12. Fournier AE, GrandPre T, Srrittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001;409:341-46
13. He XL, Bazan F, McDermott G, et al. Structure of the Nogo receptor ectodomain: A recognition module implicated in myelin inhibition. Neuron 2003;38:177-85
14. Hunt D, Mason MRJ, Campbell G, et al. Nogo receptor mRNA expression in intact and regenerating CNS neurons. Mol Cell Neurosci 2002;20: 537-52
15. Josephson A, Trifunovski A, Widmer HR, et al. Nogo-receptor gene activity: Cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol 2002;453:292-304
16. Wang KC, Kim JA, Sivasankaran R, et al. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002;420:74-78
17. Niederöst B, Oertle T, Fritsche J, et al. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Racl. J Neurosci 2002;22:10368-76
18. Bareyre FM, Haudenschild B, Schwab ME. Long-lasting sprouting and gene expression changes induced by the monoclonal antibody IN-1 in the adult spinal cord. J Neurosci 2002;22:7097-110
19. Fournier AE, Gould GC, Liu BP, et al. Truncated soluble Nogo receptor binds to Nogo-66 and blocks inhibition of axonal growth by myelin. J Neurosci 2002;22:8876-83
20. GrandPré T, Li S, Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002;417:547-51
21. Ferguson B, Matyszak MK, Esiri MM, et al. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-99
22. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-85
23. Reindl M, Khantane S, Ehling R, et al. Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurologic disorders. J Neuroimmunol 2003;145:139-47
24. Buffo A, Zagrebelsky M, Huber AB, et al. Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured Purkinje cell axons. J Neurosci 2000;20:2275-86
25. Emerick AJ, Neafsey EJ, Schwab ME, et al. Functional reorganization of the motor cortex in adult rats after cortical lesion and treatment with monoclonal antibody IN-1. J Neurosci 2003;23:4826-30
26. Kim J-E, Li S, Grandpré T, et al. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 2003;38:187-99
27. Simonen M, Pedersen V, Weinmann O, et al. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2003;38:201-11
28. Zheng B, Ho C, Li S, et al. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 2003;38:213-24
29. Karnezis T, Mandemakers W, McQualter JL, et al. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci 2004;7:736-44
30. Lee J-K, Kim J-E, Sivula M, et al. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci 2004;24: 6209-17
31. Satoh J-I, Yamamura T, Arima K. The 14-3-3 protein ε isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes. Am J Pathol 2004;165:577-92
32. Satoh J-I, Kuroda Y. Cytokines and neurotrophic factors fail to affect Nogo-A mRNA expression in differentiated human neurones: implications for inflammation-related axonal regeneration in the central nervous system. Neuropathol Appl Neurobiol 2002;28: 95-106
33. Pignot V, Hein AE, Barske C, et al. Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor. J Neurochem 2003;85:717-28
34. Walmsley AR, McCombie G, Neumann U, et al. Zinc metalloproteinase- mediated cleavage of the human Nogo-66 receptor. J Cell Sci 2004; 117:4591-602
35. Taketomi M, Kinoshita N, Kimura K, et al. Nogo-A expression in mature oligodendrocytes of rat spinal cord in association with specific molecules. Neurosci Lett 2002;332:37-40
36. Ng CEL, Tang BL. Nogos and the Nogo-66 receptor: Factors inhibiting CNS neuron regeneration. J Neurosci Res 2002;67:559-65
37. Zhou C, Li Y, Nanda A, et al. HBO suppresses Nogo-A, Ng-R, or RhoA expression in the cerebral cortex after global ischemia. Biochem Biophys Res Commun 2003;309:368-76
38. Weiss J, Takizawa B, McGee A, et al. Neonatal hypoxia suppresses oligodendrocyte Nogo-A and increases axonal sprouting in a rodent model for human prematurity. Exp Neurol 2004;189:141-49
39. + channel localization. EMBO J 2003;22:5666-78
40. Meier S, Bräuer AU, Heimrich B, et al. Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure. FASEB J 2003;17:1153-55
41. Bandtlow CE, Dlaska M, Pirker S, et al. Increased expression of Nogo-A in hippocampal neurons of patients with temporal lobe epilepsy. Eur J Neurosci 2004;20:195-206
42. Dupuis L, de Aguilar J-LG, di Scala F, et al. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol Dis 2002;10:358-65
43. Magnusson C, Libelius R, Tågerud S. Nogo (Reticulon 4) expression in innervated and denervated mouse skeletal muscle. Mol Cell Neurosci 2003;22:298-307
44. O'Neill P, Whalley K, Ferretti P. Nogo and Nogo-66 receptor in human and chick: implications for development and regeneration. Dev Dyn 2004;231:109-21
45. Liao H, Duka T, Teng FYH, et al. Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. J Neurochem 2004;90:1156-62
46. Barton WA, Liu BP, Tzvetkova D, et al. Structure and axon outgrowth inhibitor binding of the nogo-66 receptor and related proteins. EMBO J 2003;22:3291-302
47. Li W, Walus L, Rabacchi SA, et al. A neutralizing anti-Nogo66 receptor monoclonal antibody reverses inhibition of neurite outgrowth by central nervous system myelin. J Biol Chem 2004;279:43780-88
48. Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 2003;6:461-67
49. He Z, Koprivica V The Nogo signaling pathway for regeneration block. Annu Rev Neurosci 2004;27:341-68
50. NTR: Novel functions and implications for diseases of the nervous system. Nat Neurosci 2002;5:1131-36
51. NTR neurotrophin receptor on glial cells in MS plaques. Neurology 1999;53:1676-82
52. Chang A, Nishiyama A, Peterson J, et al. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000;20:6404-12
53. Mufson EJ, Brashers-Krug T, Kordower JH. p75 nerve growth factor receptor immunoreactivity in the human brainstem and spinal cord. Brain Res 1992;589:115-23
54. Valdo P, Stegagno C, Mazzucco S, et al. Enhanced expression of NGF receptors in multiple sclerosis lesions. J Neuropathol Exp Neurol 2002; 61:91-98
55. Song X-Y, Zhong J-h, Wang X, et al. Suppression of p75NTR does not promote regeneration of injured spinal cord in mice. J Neurosci 2004; 24:542-46
56. NTR/NgR-independent pathways that converge at RhoA. Mol Cell Neurosci 2004;27:163-74